Cargando…

Retraction: Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6623503/ https://www.ncbi.nlm.nih.gov/pubmed/31295317 http://dx.doi.org/10.1371/journal.pone.0219887

Ejemplares similares

Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
por: Todorova, Valentina K., et al.
Publicado: (2016)

Rational Design of Multifunctional Micelles Against Doxorubicin-Sensitive and Doxorubicin-Resistant MCF-7 Human Breast Cancer Cells [Retraction]
Publicado: (2022)

Retracted: Grading Evaluation of Cardiotoxicity in Patients with Breast Cancer Treated with Adjuvant Paclitaxel Anthracycline/Cyclophosphamide Chemotherapy: A Meta-Analysis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retracted: The Value of Left Atrial Volume Changes in Predicting Cardiotoxicity in Patients Undergoing Anthracycline Chemotherapy
por: Healthcare Engineering, Journal of
Publicado: (2023)

Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer [Retraction]
Publicado: (2023)

Retracted: Study on the Application of Doxorubicin-Loaded Magnetic Nanodrugs in Targeted Therapy of Liver Cancer
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer
por: Cochera, Flavia, et al.
Publicado: (2018)

Retracted: Biomarkers for Breast Adenocarcinoma Using In Silico Approaches
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer [Retraction]
Publicado: (2022)

Retracted: Preliminary Study on the Therapeutic Effect of Doxorubicin-Loaded Targeting Nanoparticles on Glioma
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients
por: Todorova, Valentina K., et al.
Publicado: (2017)

Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients
por: Oliveira-Carvalho Vagner, Rigaud, et al.
Publicado: (2016)

Retracted: Comparison of Clinical Effects of Temozolomide Single Agent and Combined Doxorubicin in the Treatment of Glioma
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retraction: Zoledronic Acid Restores Doxorubicin Chemosensitivity and Immunogenic Cell Death in Multidrug-Resistant Human Cancer Cells
Publicado: (2020)

Retracted: Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retraction: Sinomenine Sensitizes Multidrug-Resistant Colon Cancer Cells (Caco-2) to Doxorubicin by Downregulation of MDR-1 Expression
por: Liu, Zhen, et al.
Publicado: (2019)

Retracted: Efficacy of Chinese Medicine Injection for Cardiotoxic Injury of Anthracycline Chemotherapy Drugs: A Network Meta-Analysis of Randomized Controlled Trials
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Extract of Platycodon grandiflorum Prevents Doxorubicin-induced Cardiotoxicity in Breast Cancer
por: Shi, Youyang, et al.
Publicado: (2023)

Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin [Retraction]
Publicado: (2019)

Retraction note: Rituximab-conjugated, doxorubicin-loaded microbubbles as a theranostic modality in B-cell lymphoma
por: Zhou, Shoubing, et al.
Publicado: (2017)

c(RGDyK)-Decorated Pluronic Micelles for Enhanced Doxorubicin and Paclitaxel Delivery to Brain Glioma [Retraction]
Publicado: (2022)

Retracted: Distinct Urinary Metabolic Biomarkers of Human Colorectal Cancer
por: Markers, Disease
Publicado: (2023)

Retraction: An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer
por: Salter, Kelly H., et al.
Publicado: (2011)

Retracted: Changes and Influencing Factors of Cognitive Impairment in Patients with Breast Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: Correlation between Breast Ultrasound Microcalcification and the Prognosis of Breast Cancer
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Cancer Categorization Using Genetic Algorithm to Identify Biomarker Genes
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Machine Learning Algorithms for Prediction of Survival Curves in Breast Cancer Patients
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Potential of exosomes as diagnostic biomarkers and therapeutic carriers for doxorubicin-induced cardiotoxicity
por: Tian, Chao, et al.
Publicado: (2021)

Preparation and in vitro Evaluation of Doxorubicin-Loaded Fe(3)O(4) Magnetic Nanoparticles Modified with Biocompatible Copolymers [Retraction]
Publicado: (2020)

Retracted: Effect of Paclitaxel Combined with Doxorubicin Hydrochloride Liposome Injection in the Treatment of Osteosarcoma and MRI Changes before and after Treatment
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Role of acetylation in doxorubicin-induced cardiotoxicity
por: Li, Daisong, et al.
Publicado: (2021)

Dipyridamole ameliorates doxorubicin-induced cardiotoxicity
por: Alyasiry, Esraa, et al.
Publicado: (2022)

Retracted: Analysis of Adjuvant Chemotherapy on Pathological Remission of Breast Cancer
por: and Mathematical Methods in Medicine, Computational
Publicado: (2022)

Retracted: In Silico Identification of Hub Genes as Observing Biomarkers for Gastric Cancer Metastasis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: Integrated Analysis of Circular RNA-Associated ceRNA Network Reveals Potential circRNA Biomarkers in Human Breast Cancer
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retracted: The Application of Whole-Process Case Management in Patients with Triple-Negative Breast Cancer
por: Oncology, Journal of
Publicado: (2023)

Retraction Notice to: A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID
por: Xu, Yun-chao, et al.
Publicado: (2022)

Retraction: Functional analyses of micoRNA-326 in breast cancer development
Publicado: (2021)

Retracted: Machine Learning Based Comparative Analysis for Breast Cancer Prediction
por: Healthcare Engineering, Journal of
Publicado: (2023)

Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers: Retraction
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_83m4nahs8lu8hmat8kfcd04qhg